A clinicalbiological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

By Bria E.   De Manzoni G.   Beghelli S.   Tomezzoli A.   Barbi S.   Di Gregorio C.   Scardoni M.   Amato E.   Frizziero M.   Sperduti I.   Corbo V.   Brunelli M.   Bersani S.   Tortora G.   Scarpa A.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 693-701

Oxford University Press

Access to resources Recommend Favorite

Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma

By Mandai M.   Konishi I.   Kuroda H.   Nanbu K.   Matsushita K.   Yura Y.   Hamid A.A.   Mori T.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 745-749

Elsevier

Access to resources Recommend Favorite

Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 430-436

Spandidos Publications

Access to resources Recommend Favorite

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

Absence of FHIT expression is associated with apoptosis inhibition in colorectal cancer

By Cao Jie   Chen Xiaoping   Li Wanglin   Xia Jie   Du Hong   Tang Weibiao   Wang Hui   Chen Xiwen   Xiao Huanqing   Li Yuyuan  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 1, 2007-02 ,pp. : 44-51

Springer Publishing Company

Access to resources Recommend Favorite